Trial site
Florida Cancer Specialists
- 10running trials
- 5closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer6 trials
- Lung cancer5 trials
- Ovarian cancer5 trials
- Colorectal cancer4 trials
- Pancreatic cancer4 trials
- Bladder cancer2 trials
- Endometrial cancer2 trials
- Gastric and oesophageal cancer2 trials
- Head and neck cancer2 trials
- Cervical cancer1 trial
- Kidney cancer1 trial
- Liver and biliary tract cancer1 trial
- and 3 more
- Phase
- Phase 14 trials
- Phase 1/24 trials
- Phase 34 trials
- Phase 23 trials
- Status
- Recruiting6 trials
- Active, not recruiting4 trials
- Completed4 trials
- Terminated1 trial
- Lead sponsor
- Pfizer8 trials
- Seagen, a wholly owned subsidiary of Pfizer3 trials
- Artios Pharma Ltd1 trial
- BioNTech SE1 trial
- Incyclix Bio1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Active, not recruiting
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Recruiting
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
Active, not recruiting
A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Ovarian cancer3 recruiting
- Pancreatic cancer3 recruiting
- Bladder cancer2 recruiting
- Colorectal cancer2 recruiting
- Gastric and oesophageal cancer2 recruiting
- Metastatic breast cancer2 recruiting
- Cervical cancer1 recruiting
- Endometrial cancer1 recruiting
- Head and neck cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
Closed trials
Terminated
Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Completed
A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026